| Nuclear transport receptor karyopherin-α2 promotes malignant breast cancer phenotypes in vitro E Noetzel, M Rose, J Bornemann, M Gajewski, R Knüchel, E Dahl Oncogene 31 (16), 2101-2114, 2012 | 90 | 2012 |
| Intermediate filament dynamics and breast cancer: aberrant promoter methylation of the Synemin gene is associated with early tumor relapse E Noetzel, M Rose, E Sevinc, RD Hilgers, A Hartmann, A Naami, ... Oncogene 29 (34), 4814-4825, 2010 | 79 | 2010 |
| Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype G Kristiansen, M Rose, C Geisler, FR Fritzsche, J Gerhardt, C Lüke, ... British journal of cancer 102 (12), 1736-1745, 2010 | 57 | 2010 |
| Artificial intelligence–based detection of FGFR3 mutational status directly from routine histology in bladder cancer: a possible preselection for molecular testing? CML Loeffler, NO Bruechle, M Jung, L Seillier, M Rose, NG Laleh, ... European urology focus 8 (2), 472-479, 2022 | 56 | 2022 |
| Agr3 in breast cancer: Prognostic impact and suitable serum-based biomarker for early cancer detection S Garczyk, S von Stillfried, W Antonopoulos, A Hartmann, MG Schrauder, ... PloS one 10 (4), e0122106, 2015 | 54 | 2015 |
| Endogenous Myoglobin in Breast Cancer Is Hypoxia-inducible by Alternative Transcription and Functions to Impair Mitochondrial Activity A ROLE IN TUMOR SUPPRESSION? G Kristiansen, J Hu, D Wichmann, DP Stiehl, M Rose, J Gerhardt, ... Journal of Biological Chemistry 286 (50), 43417-43428, 2011 | 54 | 2011 |
| Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours M Rose, NT Gaisa, P Antony, D Fiedler, A Heidenreich, W Otto, ... Carcinogenesis 35 (3), 727-736, 2014 | 53 | 2014 |
| Epigenetic inactivation of ST6GAL1 in human bladder cancer P Antony, M Rose, A Heidenreich, R Knüchel, NT Gaisa, E Dahl BMC cancer 14, 1-11, 2014 | 52 | 2014 |
| ITIH5 mediates epigenetic reprogramming of breast cancer cells M Rose, V Kloten, E Noetzel, L Gola, J Ehling, T Heide, SK Meurer, ... Molecular cancer 16 (1), 44, 2017 | 40 | 2017 |
| OASIS/CREB3L1 is epigenetically silenced in human bladder cancer facilitating tumor cell spreading and migration in vitro M Rose, C Schubert, L Dierichs, NT Gaisa, M Heer, A Heidenreich, ... Epigenetics 9 (12), 1626-1640, 2014 | 39 | 2014 |
| Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients M Schlensog, L Magnus, T Heide, J Eschenbruch, F Steib, M Tator, ... Epigenetics 13 (3), 214-227, 2018 | 38 | 2018 |
| Epigenetic inactivation of the novel candidate tumor suppressor gene ITIH5 in colon cancer predicts unfavorable overall survival in the CpG island methylator … V Kloten, M Rose, S Kaspar, S von Stillfried, R Knüchel, E Dahl Epigenetics 9 (9), 1290-1301, 2014 | 37 | 2014 |
| EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancer M Rose, A Maurer, J Wirtz, A Bleilevens, T Waldmann, M Wenz, M Eyll, ... Oncogene 39 (44), 6856-6870, 2020 | 35 | 2020 |
| Promoter methylation of DNA damage repair (DDR) genes in human tumor entities: RBBP8/CtIP is almost exclusively methylated in bladder cancer J Mijnes, J Veeck, NT Gaisa, E Burghardt, TC de Ruijter, S Gostek, E Dahl, ... Clinical epigenetics 10 (1), 1-20, 2018 | 34 | 2018 |
| BDNF is associated with SFRP1 expression in luminal and basal-like breast cancer cell lines and primary breast cancer tissues: a novel role in tumor suppression? L Huth, M Rose, V Kloubert, W Winkens, M Schlensog, A Hartmann, ... PloS one 9 (7), e102558, 2014 | 32 | 2014 |
| ITIH5 induces a shift in TGF‐β superfamily signaling involving Endoglin and reduces risk for breast cancer metastasis and tumor death M Rose, SK Meurer, V Kloten, R Weiskirchen, B Denecke, ... Molecular carcinogenesis 57 (2), 167-181, 2018 | 29 | 2018 |
| Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation R Morsch, M Rose, A Maurer, MA Cassataro, T Braunschweig, R Knüchel, ... BMC cancer 20, 1-10, 2020 | 28 | 2020 |
| Comparative genomic profiling of glandular bladder tumours A Maurer, N Ortiz-Bruechle, K Guricova, M Rose, R Morsch, S Garczyk, ... Virchows Archiv 477, 445-454, 2020 | 27 | 2020 |
| Fibroblast growth factor receptor (FGFR) alterations in squamous differentiated bladder cancer: a putative therapeutic target for a small subgroup PH Baldia, A Maurer, T Heide, M Rose, R Stoehr, A Hartmann, ... Oncotarget 7 (44), 71429, 2016 | 26 | 2016 |
| Oncogenic features of neuromedin U in breast cancer are associated with NMUR2 expression involving crosstalk with members of the WNT signaling pathway S Garczyk, N Klotz, S Szczepanski, B Denecke, W Antonopoulos, ... Oncotarget 8 (22), 36246-36265, 2017 | 21 | 2017 |
